Press releases
- US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for immunocompromised adults aged 19 and up
- Less talk, more action: New report sponsored by ViiV Healthcare provides roadmap to achieve health equity by 2040
- GSK to showcase significant scientific advances in renal care at the American Society of Nephrology Kidney Week 2021
Tweets from GSK US
-
GSKUS @GSKUS
Living with Chronic Rhinosinusitis with Nasal Polyps can be challenging. GSK is committed to advancing care for patients who need it. Listen to Dr. Jared Silver, U.S. Medical Affairs, discuss how GSK is continuing to address unmet needs of patients and educate HCPs. #CHEST2021
about 5 hours ago -
GSKUS @GSKUS
As #CHEST2021 concludes, it’s more important than ever to recognize the impact of #COVID19 on those living with respiratory conditions. Carl Abbott, PharmD, GSK U.S. Medical Affairs, discusses why below 👀R
about 7 hours ago -
GSKUS @GSKUS
Why is lung health important, and what is GSK doing to stay ahead of disease? Watch below to hear from Dr. Tom Corbridge, GSK U.S. Senior Medical Lead 👇#CHEST20211H
about 8 hours ago
